These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 4986769)

  • 1. Dissociation of antibody production from disease suppression in the inhibition of allergic encephalomyelitis by myelin basic protein.
    Lisak RP; Falk GA; Heinze RG; Kies MW; Alvord EC
    J Immunol; 1970 Jun; 104(6):1435-46. PubMed ID: 4986769
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationships between antibodies and experimental allergic encephalomyelitis. 3. Coprecipitation and radioautography of 125I-labeled antigen-antibody complexes for detection of antibodies to myelin basic protein.
    Lisak RP; Heinze RG; Kies MW
    Int Arch Allergy Appl Immunol; 1970; 37(6):621-9. PubMed ID: 4983347
    [No Abstract]   [Full Text] [Related]  

  • 3. Delayed hypersensitivity to myelin basic protein in the passive transfer of experimental allergic encephalomyelitis.
    Falk GA; Kies MW; Alvord EC
    J Immunol; 1968 Oct; 101(4):638-44. PubMed ID: 4971475
    [No Abstract]   [Full Text] [Related]  

  • 4. Antigen-induced inhibition of experimental allergic encephalomyelitis. I. Inhibition in guinea pigs injected with non-encephalitogenic modified myelin basic protein.
    Swanborg RH
    J Immunol; 1972 Sep; 109(3):540-6. PubMed ID: 4626655
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prevention of development of experimental allergic encephalomyelitis by encephalitogenic protein].
    Zhitnukhin IuL; Sofronov BN; Beme DKh; Baĭkovskaia MN
    Patol Fiziol Eksp Ter; 1978; (5):55-60. PubMed ID: 83596
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunologic properties of the main encephalitogenic peptide from the basic protein of human myelin.
    Lennon VA; Wilks AV; Carnegie PR
    J Immunol; 1970 Nov; 105(5):1223-30. PubMed ID: 4099924
    [No Abstract]   [Full Text] [Related]  

  • 7. Passive transfer of experimental allergic encephalomyelitis: mechanisms of suppression.
    Falk GA; Kies MW; Alvord EC
    J Immunol; 1969 Dec; 103(6):1248-53. PubMed ID: 5361563
    [No Abstract]   [Full Text] [Related]  

  • 8. Mycobacterial suppression of delayed hypersensitivity in experimental allergic encephalomyelitis.
    Lisak RP; Kies MW
    Proc Soc Exp Biol Med; 1968 May; 128(1):214-8. PubMed ID: 4968539
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunologic unresponsiveness, immunity and enhancement in experimental allergic encephalomyelitis.
    Salvin SB; Liauw HL
    J Immunol; 1968 Jul; 101(1):33-42. PubMed ID: 4173936
    [No Abstract]   [Full Text] [Related]  

  • 10. Delayed hypersensitivity to Trichinella spiralis. 3. Effect of repeated sensitizations in donors and recipients.
    Kim CW; Jamuar MP; Hamilton LD
    J Immunol; 1970 Jul; 105(1):175-86. PubMed ID: 4246565
    [No Abstract]   [Full Text] [Related]  

  • 11. Skin-fixing antibody in experimental allergic encephalomyelitis.
    Falk GA; Heinze RG; Kies MW; Alvord EC
    J Immunol; 1968 Feb; 100(2):321-8. PubMed ID: 5639700
    [No Abstract]   [Full Text] [Related]  

  • 12. The specificity of the early immune response. I. A comparison of the specificity of delayed hypersensitivity and humoral responses following immunization with human gammaG globulin.
    Henney CS
    J Immunol; 1969 Sep; 103(3):519-27. PubMed ID: 4979779
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibodies to encephalitogenic basic protein in experimental allergic encephalomyelitis.
    Lisak RP; Heinze RG; Kies MW; Alvord EC
    Proc Soc Exp Biol Med; 1969 Mar; 130(3):814-8. PubMed ID: 4975295
    [No Abstract]   [Full Text] [Related]  

  • 14. Multiplicity of encephalitogenic myelin basic proteins. II. Antigenic determinants related to species of origin and molecular size.
    Alvord EC; Hruby S; Shaw CM; Kies MW
    Int Arch Allergy Appl Immunol; 1969; 36():Suppl:203-17. PubMed ID: 4984656
    [No Abstract]   [Full Text] [Related]  

  • 15. Susceptibility and resistance to experimental autoimmune encephalomyelitis and neuritis in the guinea pig correlate with the induction of procoagulant and anticoagulant activities.
    Geczy CL; Roberts IM; Meyer P; Bernard CC
    J Immunol; 1984 Dec; 133(6):3026-36. PubMed ID: 6208270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of peripheral lymphocytes in the course of experimental allergic encephalomyelitis in the guinea-pig.
    Pekárek J; Vepreková A; Doutlík S
    Z Immunitatsforsch Exp Klin Immunol; 1972 Mar; 143(2):139-46. PubMed ID: 4143076
    [No Abstract]   [Full Text] [Related]  

  • 17. Antigen-induced inhibition of experimental allergic encephalomyelitis. II. Studies in guinea pigs with the small rat myelin basic protein.
    Swanborg RH
    J Immunol; 1973 Oct; 111(4):1067-70. PubMed ID: 4728676
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of experimental allergic encephalomyelitis by bacterial lipopolysaccharides: inhibition of cell-mediated immunity.
    Raziuddin S; Kibler RF; Morrison DC
    J Immunol; 1981 Jul; 127(1):13-6. PubMed ID: 6165758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of experimental allergic encephalomyelitis by nonencephalitogenic basic peptides.
    Hashim GA; Schilling FJ
    Arch Biochem Biophys; 1973 May; 156(1):287-97. PubMed ID: 4125887
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro and in vivo immune responses to homologous myelin basic protein in experimental allergic encephalomyelitis.
    Lisak RP; Zweiman B
    Cell Immunol; 1974 Mar; 11(1-3):212-20. PubMed ID: 4141935
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.